Skip to main content
Netherlands News in English

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
Pills
Pills - Credit: Photo: motorolka/DepositPhotos
Health
obesity
obesity medicine
National Healthcare Institute
NZa
Saxenda
Maurits de Brauw
Spaarne Gasthuis
Ignace Janssen
Dutch Obesity Clinic
Liesbeth van Rossum
Erasmus MC
Mireille Serlie
Amsterdam UMC
Tuesday, 19 April 2022 - 10:30

Share this article:

Make obesity medicine available to more people: doctors

Medicines against obesity must be available to more people, obesity doctors said to newspaper AD. Too many people can't access these medicines, while losing weight can make them less susceptible to diseases like diabetes and heart problems, the doctors said. About 14 percent of Netherlands residents suffer from obesity.

The National Healthcare Institute approved the first medicine to treat obesity last month. The drug, Saxenda, reduces the feeling of hunger, among other things. The basic health insurance package reimburses the medicine for people with a body mass index (BMI) of 40 or higher or with a BMI of 35 or higher with underlying health problems. The patients must also follow a special program in which they work on a healthier lifestyle with a lifestyle coach.

That is a very limited group, Maurits de Brauw, obesity surgeon at the Spaarne Gasthuis, said to AD. "It concerns about 650 people annually, while hundreds of thousands of people are overweight."

A healthy BMI is between 18 and 25. Ignace Janssen, medical director of the Dutch Obesity Clinic, thinks obesity medicine like Saxenda should be prescribed for people with a BMI from 27. "Patients have to change their lifestyle. That is not easy if you are constantly hungry. This medicine makes that easier," Janssen said to the newspaper.

But as insurance doesn't cover the medicine for them, they have to pay some 2,600 euros annually out of their own pocket. And not all patients can afford that. "The door is ajar, but an incredible number of people are missing out," Liesbeth van Rossum, internist-endocrinologist and professor of obesity at Erasmus MC, said to AD. "Being overweight leads to over 200 other diseases. It is better to tackle the source."

Mireille Serlie, professor and internist-endocrinologist at Amsterdam UMC, would also like to give more patients this option. "As you gain weight, the risk of diabetes and cardiovascular disease increases. It is imperative that effective medication is available to lose weight and inhibit further weight gain."

More like this

Image
Erasmus MC in Rotterdam
More people need liver transplants as obesity increases
Image
Ozempic
Ozempic overdose: More poisonings with weight loss drugs
Image
French fries
Nearly two-thirds of Dutch will be overweight by 2050: RIMV
Image
Packaging box of Wegovy (semaglutide), an injectable prescription medication, weight-loss drug by pharmaceutical Novo Nordisk, in a pharmacy
Ozempic-cousin Wegovy unlikely to be covered by basic Dutch health insurance
Make NL Times your top Google source

Follow us:

Latest stories

  • Trust and interest in news continue to fall in the Netherlands, report finds
  • Negligence alleged in crash that killed 3 kids, school principal biking in Zeeland
  • Netherlands bans gay conversion therapy after Senate majority backs new law
  • Dutch meat sector again promises improvement after new threat to ban foreign workers
  • Weeronline warns of heat stress as tropical weather arrives on Thursday

Top stories

  • Negligence alleged in crash that killed 3 kids, school principal biking in Zeeland
  • Netherlands bans gay conversion therapy after Senate majority backs new law
  • Video: Boy riding fatbike shot in front of Gouda grocery store
  • Boy, 2, dies after fall from window of Rotterdam home
  • Amsterdam to tackle discrimination, violent incidents with priority during World Pride

© 2012-2026, NL Times, All rights reserved.

Footer menu

  • Change Privacy Settings
  • Privacy Policy
  • Contact
  • Partner Content